Skip to main content
. Author manuscript; available in PMC: 2019 May 16.
Published in final edited form as: Biomed Pharmacother. 2003 May-Jun;57(3-4):145–155. doi: 10.1016/s0753-3322(03)00043-x

Table 5.

GSTM1 polymorphism

Allele Frequency in Caucasian populations Cancer risks
M1*A 0.2 Decreased risk of bladder and breast cancer
M1*B 0.2 Decreased risk ofpituitary adenomas
M1*0 0.59 Increased risk of lung, colon, bladder, and post-menopausal breast cancer